UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Hospitalization for Respiratory Syncytial Virus in Children with Down Syndrome Less than 2 Years of Age: A Systematic Review and Meta-Analysis

The Journal of pediatrics, 2018-12, Vol.203, p.92-100.e3

2018

Volltextzugriff (PDF)

A new cost-utility analysis assessing risk factor-guided prophylaxis with palivizumab for the prevention of severe respiratory syncytial virus infection in Italian infants born at 29-35 weeks' gestational age

PloS one, 2023-08, Vol.18 (8), p.e0289828-e0289828

2023

Volltextzugriff (PDF)

Understanding Policy Decisions and Their Implications Regarding Preventive Interventions for Respiratory Syncytial Virus (RSV) Infection in Canadian Infants: A Primer for Nurses

Neonatal network, 2023-08, Vol.42 (5), p.291-302

2023

Volltextzugriff (PDF)

Respiratory Syncytial Virus Immunoprophylaxis with Palivizumab: 12-Year Observational Study of Usage and Outcomes in Canada

American journal of perinatology, 2022-11, Vol.39 (15), p.1668-1677

2022

Volltextzugriff (PDF)

Defining the Epidemiology and Burden of Severe Respiratory Syncytial Virus Infection Among Infants and Children in Western Countries

Infectious diseases and therapy, 2016-09, Vol.5 (3), p.271-298

2016

Volltextzugriff (PDF)

Indications and outcomes of neonatal intubation: A single-center, prospective study in a middle-income country

Pediatrics and neonatology, 2022-03, Vol.63 (2), p.125-130

2022

Volltextzugriff (PDF)

Respiratory Syncytial Virus Prophylaxis in Immunocompromised Children: Outcomes From the Canadian RSV Evaluation Study of Palivizumab Registry Over Twelve Seasons (2005-2017)

The Pediatric infectious disease journal, 2020-06, Vol.39 (6), p.539-545

2020

Volltextzugriff (PDF)

The association of platelets with failed patent ductus arteriosus closure after a primary course of indomethacin or ibuprofen: a systematic review and meta-analysis

The journal of maternal-fetal & neonatal medicine, 2017-01, Vol.30 (2), p.127-133

2017

Volltextzugriff (PDF)

Past, Present and Future Approaches to the Prevention and Treatment of Respiratory Syncytial Virus Infection in Children

Infectious diseases and therapy, 2018-03, Vol.7 (1), p.87-120

2018

Volltextzugriff (PDF)

Pediatric superior vena cava syndrome: An evidence‐based systematic review of the literature

Pediatric blood & cancer, 2018-09, Vol.65 (9), p.e27225-n/a

2018

Volltextzugriff (PDF)

Impact of using the International Risk Scoring Tool on the cost-utility of palivizumab for preventing severe respiratory syncytial virus infection in Canadian moderate-to-late preterm infants

Journal of medical economics, 2023-12, Vol.26 (1), p.630-643

2023

Volltextzugriff (PDF)

Respiratory Syncytial Virus Prophylaxis in Neurologic and Muscular Disorders in the Canadian Respiratory Syncytial Virus Evaluation Study of Palivizumab

The Pediatric infectious disease journal, 2019-08, Vol.38 (8), p.775-780

2019

Volltextzugriff (PDF)

Patent foramen ovale and stroke in childhood: A systematic review of the literature

European journal of paediatric neurology, 2016-07, Vol.20 (4), p.500-511

2016

Volltextzugriff (PDF)

Use of thrombolytic agents to treat neonatal thrombosis in clinical practice

Blood coagulation & fibrinolysis, 2022-06, Vol.33 (4), p.193-200

2022

Volltextzugriff (PDF)

Comparison of the SenSmart™ and the INVOS™ neonatal cerebral near-infrared spectrometry devices

Frontiers in pediatrics, 2023-08, Vol.11, p.1243977-1243977

2023

Volltextzugriff (PDF)

Accuracy of transcutaneous bilirubin measured by the BiliCare device in late preterm and term neonates

The journal of maternal-fetal & neonatal medicine, 2016-11, Vol.29 (22), p.3641-3645

2016

Volltextzugriff (PDF)

Comparing First- and Second-year Palivizumab Prophylaxis in Patients With Hemodynamically Significant Congenital Heart Disease in the CARESS Database (2005-2015)

The Pediatric infectious disease journal, 2017-05, Vol.36 (5), p.445

2017

Volltextzugriff (PDF)

Opinion: The optimal use of risk factors to guide palivizumab prophylaxis against severe respiratory syncytial virus infection in moderate-to-late preterm infants

Frontiers in pediatrics, 2024, Vol.12, p.1343960-1343960

2024

Volltextzugriff (PDF)

Comparing First- and Second-year Palivizumab Prophylaxis in Patients With Hemodynamically Significant Congenital Heart Disease in the CARESS Database (2005–2015)

The Pediatric infectious disease journal, 2016-10, Vol.36 (5), p.445-450

2016

Volltextzugriff (PDF)

Seasonal respiratory syncytial virus prophylaxis based on predetermined dates versus regional surveillance data

The Pediatric infectious disease journal, 2013-09, Vol.32 (9), p.e360-e364

2013

Volltextzugriff (PDF)

Impact of level of neonatal care on phlebotomy and blood transfusion in extremely low birthweight infants: a prospective, multicenter, observational study

Frontiers in pediatrics, 2023-09, Vol.11, p.1238402-1238402

2023

Volltextzugriff (PDF)

Respiratory syncytial virus hospitalization and incurred morbidities the season after prophylaxis

Paediatrics & child health, 2018-11, Vol.23 (7), p.441-446

2018

Volltextzugriff (PDF)

CARESS: the Canadian registry of palivizumab

The Pediatric infectious disease journal, 2011-08, Vol.30 (8), p.651-655

2011

Volltextzugriff (PDF)

Comparison of the Canadian vs. the international risk scoring tool for respiratory syncytial virus prophylaxis in moderate-to-late preterm infants

Frontiers in pediatrics, 2023-01, Vol.10, p.997349-997349

2023

Volltextzugriff (PDF)

Respiratory syncytial virus prophylaxis in Down syndrome: a prospective cohort study

Pediatrics (Evanston), 2014-06, Vol.133 (6), p.1031-1037

2014

Volltextzugriff (PDF)

1 – 25 von 250

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(232)
Mit Volltextzugriff
(175)

Publikationsform

Artikel
(240)
Berichte
(5)
Reviews
(5)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(178)
Life Sciences & Biomedicine
(174)
Humans
(150)
Infant, Newborn
(116)
Pediatrics
(91)
Female
(77)
Respiratory Syncytial Virus
(73)
Male
(63)
Infant
(57)
Palivizumab
(53)
Respiratory Syncytial Virus Infections - Prevention & Control
(48)
Risk Factors
(48)
Biological And Medical Sciences
(46)
Medical Sciences
(35)
Infectious Diseases
(34)
Hospitalization
(33)
Gestational Age
(27)
Respiratory Syncytial Virus Infections - Epidemiology
(27)
Antiviral Agents - Therapeutic Use
(26)
Infant, Premature
(24)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Hospitalization for Respiratory Syncytial Virus in Children with Down Syndrome Less than 2 Years of Age: A Systematic Review and Meta-Analysis

A new cost-utility analysis assessing risk factor-guided prophylaxis with palivizumab for the prevention of severe respiratory syncytial virus infection in Italian infants born at 29-35 weeks' gestational age

Understanding Policy Decisions and Their Implications Regarding Preventive Interventions for Respiratory Syncytial Virus (RSV) Infection in Canadian Infants: A Primer for Nurses

Respiratory Syncytial Virus Immunoprophylaxis with Palivizumab: 12-Year Observational Study of Usage and Outcomes in Canada

Defining the Epidemiology and Burden of Severe Respiratory Syncytial Virus Infection Among Infants and Children in Western Countries

Indications and outcomes of neonatal intubation: A single-center, prospective study in a middle-income country

Respiratory Syncytial Virus Prophylaxis in Immunocompromised Children: Outcomes From the Canadian RSV Evaluation Study of Palivizumab Registry Over Twelve Seasons (2005-2017)

The association of platelets with failed patent ductus arteriosus closure after a primary course of indomethacin or ibuprofen: a systematic review and meta-analysis

Past, Present and Future Approaches to the Prevention and Treatment of Respiratory Syncytial Virus Infection in Children

Pediatric superior vena cava syndrome: An evidence‐based systematic review of the literature

Impact of using the International Risk Scoring Tool on the cost-utility of palivizumab for preventing severe respiratory syncytial virus infection in Canadian moderate-to-late preterm infants

Respiratory Syncytial Virus Prophylaxis in Neurologic and Muscular Disorders in the Canadian Respiratory Syncytial Virus Evaluation Study of Palivizumab

Patent foramen ovale and stroke in childhood: A systematic review of the literature

Use of thrombolytic agents to treat neonatal thrombosis in clinical practice

Comparison of the SenSmart™ and the INVOS™ neonatal cerebral near-infrared spectrometry devices

Accuracy of transcutaneous bilirubin measured by the BiliCare device in late preterm and term neonates

Comparing First- and Second-year Palivizumab Prophylaxis in Patients With Hemodynamically Significant Congenital Heart Disease in the CARESS Database (2005-2015)

Opinion: The optimal use of risk factors to guide palivizumab prophylaxis against severe respiratory syncytial virus infection in moderate-to-late preterm infants

Comparing First- and Second-year Palivizumab Prophylaxis in Patients With Hemodynamically Significant Congenital Heart Disease in the CARESS Database (2005–2015)

Seasonal respiratory syncytial virus prophylaxis based on predetermined dates versus regional surveillance data

Impact of level of neonatal care on phlebotomy and blood transfusion in extremely low birthweight infants: a prospective, multicenter, observational study

Respiratory syncytial virus hospitalization and incurred morbidities the season after prophylaxis

CARESS: the Canadian registry of palivizumab

Comparison of the Canadian vs. the international risk scoring tool for respiratory syncytial virus prophylaxis in moderate-to-late preterm infants

Respiratory syncytial virus prophylaxis in Down syndrome: a prospective cohort study

Suchergebnisse filtern